Mizuho Maintains Neutral on Abbott Laboratories, Raises Price Target to $130

Benzinga · 10/17 13:16
Mizuho analyst Anthony Petrone maintains Abbott Laboratories (NYSE:ABT) with a Neutral and raises the price target from $115 to $130.